The company is developing a search application that will allow users to explore genomic datasets without accessing sensitive information.
Transforming Medicine: The Elizabeth Kauffman Institute plans to develop a knowledgebase for evaluating patient information, including genetic and molecular data.
The company has signed an agreement for the purchase and sale of 1,200,000 shares of common stock.
NicheVision will distribute Battelle's ExactID to law enforcement, government, and commercial entities.
CiViC provides a communal forum for capturing and sharing written summaries, drawn from published literature, about the clinical relevance of mutations found in cancer.
The NIH has issued a preliminary guidance for newborn dried blood spot research.
Wired writes that CRISPR could change the world — in many imaginative ways — and whether it will be for the better is still in the air.
In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.
In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.